Printer Friendly

Articles from The Fly (March 18, 2019)

1-120 out of 120 article(s)
Title Author Type Words
3M realigns company to four business segments, announces leadership. 322
Active trading in Micron options ahead of earnings. 118
Aerpio Pharmaceuticals says TIME-2b study did not meet primary endpoint. 283
Aimmune announces FDA acceptance of BLA filing for AR101. 261
Aimmune falls 2% after peanut allergy drug gets standard 12 month review. 148
Aimmune news derisking, but no expedited review, says Piper Jaffray. 102
Amarin: Vascepa provides 30% risk reduction in total cardiovascular events. 101
Anavex announces first patient dosed in Phase 2 Anavex2-73 trial. Clinical report 129
Andreessen denies meeting with Cambridge whistleblower, BI reports. 125
Apple announces new 10.5" iPad Air, 7.9" iPad mini. 172
Apple Heart Study 'portends positively' for iRhythm, says Canaccord. 193
Aquestive Therapeutics recent selloff a buying opportunity, says Wedbush. 121
ARCA Biopharma announces publication of PDE3A gene data. Drug overview 329
ArcLight affiliate to buy American Midstream Partners units for $5.25 per unit. 309
Arrowhead files IND for Phase 2/3 study of ARO-AAT. Report 175
Asian Market Wrap:. 159
AstraZeneca says FARXIGA reduced major adverse cardiovascular events by 16%. 204
Axos Bank receives regulatory approval for MWABank deposit acquisition. 115
Biohaven secures FDA PRV to use with NDA submission of rimegepant Zydis ODT. 154
BioScrip downgraded to Equal Weight from Overweight at Stephens. 111
BioScrip outlook positive following 'unexpected' merger, say Lake Street. 103
Broadcom price target raised to $350 from $325 at Argus. 101
Call writers open new positions in USA Tech far upside strikes. 110
Calls lead puts 3:1 as Snap shares see modest weakness. 124
Canaccord, while disappointed with merger terms, remains buyer of BioScrip. 110
Chipotle price target raised to $725 from $661 at Piper Jaffray. 159
Citi abandons plan for bank-backed cryptocurrency, CoinDesk reports. 121
Coty announces board recommendation regarding tender offer by JAB Holding. 429
Dare Bioscience announces publication of clinical findings for DARE-VVA1. 622
Dermira shares may rally to $15 or higher on today's data, says Mizuho. 155
Dermira: All 3 doses of lebrikizumab met primary endpoint. 307
Deutsche Bank CEO says to review options 'that present themselves'. 258
Dine Brands, Gerry's Group announce deal to bring IHOP locations to Pakistan. 201
DPW Holdings provides update on distribution of shares in Digital Farms. 112
Eidos Therapeutics reports publication of AG10 trial in JACC. Clinical report 207
Enanta completes enrollment in two ongoing Phase 2 studies. Clinical report 160
Esperion presents Phase 3 results from Study 2 of bempedoic acid at ACC. 192
Euro$ interest rate futures are lower. 110
Facebook looking to emulate WeChat ecosystem, says Oppenheimer. 112
Fed funds futures are little changed, though deferred contracts are fractionally lower. 118
Fed policy outlook: the FOMC meeting headlines tHIS week. 258
FIS to acquire Worldpay in cash, stock deal valued at $43B. 374
Fly Intel: Pre-market Movers. 158
Fly Intel: Top five analyst downgrades. 248
Fly Intel: Top five analyst upgrades. 241
FOMC Forecast revisions. 247
Franklin Resources CFO Ken Lewis to retire, Matthew Nicholls to succeed. 128
FX Update: The dollar has traded mostly weaker. 246
FX Update: USD-JPY has maintained less than a 15 pip range. 276
GE free cash flow outlook 'battered but largely intact,' says Barclays. 114
GP Strategies reports Q4 adj. EPS 11c, consensus 29c. Financial report 189
Heavy selling in iShares Large Cap China Fund as shares tick higher. 133
Hollywood stars to attend Apple event to reveal streaming plans, NY Times says. 135
Horizon Global CEO: 'we are experiencing a slow start' to spring, summer season. 132
Huntsman sees Q1 adj. EBITDA down 10% below Q4. 403
Innovate Bio reports securities purchase agreement with SDS Capital. 129
Intel, DoE to deliver first exascale supercomputer. 191
International Bancshares reports 19% increase in cash dividend to 50c per share. 136
Intesa says Deutsche-Commerzbank deal doesn't signal wider M&A, Reuters reports. 109
Kevin Tsujihara ousted as Warner Bros. CEO, CNBC reports. 115
Kraft Heinz delay a setback, but shouldn't impact debt covenants, says Stifel. 119
Lumber Liquidators CFO Martin Agard to resign, Timothy Mulvaney named interim. 102
Lumber Liquidators enters MOU with plaintiffs in Gold litigation. 141
Lyft offering 30.77M shares of common stock in IPO, launches roadshow. 107
Mack-Cali Realty receives notice of director nominations from Bow Street. 107
Manulife Financial says 'pleased' with ruling in Mosten litigation. 182
Marriott sees EPS $7.65-$8.50 by 2021. 225
Microsoft forms Northwest Quantum Nexus coalition with PNNL, UWashington. 204
Money market rates are a bit easier. 134
Morgan Stanley surprised Micron didn't preannounce. 127
Muddy Waters comments on Boeing after Seattle Times story. 174
Mylan Institutional LLC initiates voluntary recall of Levoleucovorin Injection. 118
NAHB housing market index was unchanged at 62 in March. 115
Needham downgrades Facebook to Hold on strategy pivot, regulatory risks. 130
New Mallinckrodt CFO 'external sign of confidence,' says Canaccord. 131
Novo Nordisk settles U.S. patent litigation on Victoza with Teva. 170
Okta upgraded to Buy from Neutral at Goldman Sachs. 134
ON Semiconductor has introduced two new silicon carbide, SiC Mosfet devices. 108
Orchard Therapeutics appoints Ran Zheng CTO. 127 says Guggenheim engaged to help evaluate strategic initiatives. 287
PepsiCo announces senior leadership appointments for Latin America business. 181
Piper pokes holes in Dermira data, says buy Regeneron on selloff. 173
Piper sees minimal impact from FDA review of paclitaxel coated devices. 177
Pixelworks enters independent software vendor agreement with Qualcomm. 139
PolarityTE reports revenue of $0.7M for two month transitional period. Financial report 175
Precision Drilling announces sale of certain assets. 316
Protalix CEO says '2019 could be a transformational year for us'. 199
Proteon Therapeutics price target raised to $4 from $3 at H.C. Wainwright. 111
Quest Diagnostics assumed with a Neutral at Credit Suisse. 104
Radius Health to present Phase 3 ACTIVE analysis at ENDO. 110
Regulus reports Q4 EPS (98c), consensus (92c). Financial report 127
ResTORbio announces planned initiation for RTB101 Phase 3 program. 372
Rockwell Medical reports results from two studies of Triferic. 156
S&P higher, Dow weighed down again by Boeing in early trading. 119
S&P places Kraft Heinz on CreditWatch with negative implications. 153
Sanofi says working on plan to find new CEO, Reuters reports. 119
Selecta Biosciences price target cut to $13 from $25 at Canaccord. 106
Semtech price target raised to $63 from $60 at Loop Capital. 108
Sony Playstation, EA announce first season of Apex Legends starts March 19. 103
SPS Commerce price target raised to $120 from $112 at Oppenheimer. 102
Star Group names Jeffrey Woosnam CEO, Jeffrey Hammond COO. 199
StarKist enters settlement with Kroger, retailers over antitrust litigation. 123
Steel Dynamics sees Q1 EPS 88c-92c, consensus $1.07. Financial report 295
Surmodics says assessing impact of FDA communication on TRANSCEND trial. 334
Taiwan Liposome doses first patient in TLC590 Phase II trial. 177
Takeda receives FDA approval to manufacture FLEXBUMIN at Georgia facility. 108
Translate Bio announces publication of preclinical data from MRT platform. 220
Treasury Action: yields pulled back from highs. 129
Treasury Market Outlook: Treasury yields are little changed. 241
Treasury's $87 B 3- and 6-month bill sale was mixed, but on the soft side. 144
Trump says 'much better' carmakers coming to U.S., GM 'let our Country down'. 121
U.K. speaker says parliament won't vote again on Brexit deal, WSJ reports. 154
U.S. equities are again on a mixed footing. 206
U.S. equities stalled out and pulled back from highs. 219
Ulta Beauty price target raised to $340 from $315 at Loop Capital. 112
ViaSat, MDA win award from Canadian Department of National Defence. 113
Vodafone, Nokia sign LTE rollout deal. 120
Walmart calls lead puts 3:1 and implied volatility is at 52-week lows. 106
William Blair upgrades Dentsply Sirona after encouraging dental conference. Conference news 126
Worldpay jumps 11% to $109.14 following $43B merger with FIS. 193

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters